| Period | UVV | SPY | Delta |
|---|---|---|---|
| 3M | +0.4% | +11.4% | -10.9% |
| 6M | +2.1% | +8.2% | -6.1% |
| 1Y | -11.6% | +22.9% | -34.5% |
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Sales and other operating revenues | $2.92B-0.8% | $2.95B+7.2% | $2.75B+7.0% | $2.57B+22.2% | $2.10B |
| Cost of goods sold | $2.41B+0.6% | $2.40B+8.4% | $2.21B+4.8% | $2.11B+24.6% | $1.69B |
| Selling, general and administrative expenses | $300.7M-1.5% | $305.3M-1.7% | $310.6M+12.0% | $277.2M+15.2% | $240.7M |
| Restructuring and impairment costs | $1.8M-82.7% | $10.6M+200.1% | $3.5M | $0-100.0% | $10.5M |
| Goodwill, Impairment Loss | $41.1M | $0 | $0 | — | — |
| Operating income | $168.5M-27.6% | $232.8M+4.9% | $222.0M+22.6% | $181.1M+12.9% | $160.3M |
| Equity in pretax earnings of unconsolidated affiliates | $3.4M-62.3% | $9.1M+1104.1% | $756K-68.3% | $2.4M-60.9% | $6.1M |
| Pension settlement charge | $0-100.0% | $14.1M | $0 | $0 | — |
| Other non-operating income | $2.8M+10.8% | $2.6M-16.7% | $3.1M+72.2% | $1.8M-33.3% | $2.7M |
| Interest income | $2.0M-43.6% | $3.5M-22.7% | $4.5M-25.2% | $6.0M+556.8% | $917K |
| Interest expense | $74.0M-7.0% | $79.6M+20.2% | $66.3M+34.4% | $49.3M+77.7% | $27.7M |
| Income before income taxes | $102.7M-33.4% | $154.2M-6.0% | $164.1M+15.6% | $142.0M-0.2% | $142.3M |
| Income taxes | $46.7M+13.9% | $40.9M+31.6% | $31.1M+165.1% | $11.7M-69.7% | $38.7M |
| Net income | $56.0M-50.6% | $113.3M-14.8% | $133.0M+2.1% | $130.2M+25.7% | $103.6M |
| Less: net income attributable to noncontrolling interests in subsidiaries | -$23.4M-28.2% | -$18.2M-36.3% | -$13.4M-116.3% | -$6.2M+63.7% | -$17.0M |
| Net income attributable to Universal Corporation | $32.6M-65.7% | $95.0M-20.5% | $119.6M-3.6% | $124.1M+43.3% | $86.6M |
| Basic | $25.04B+0.4% | $24.95B+0.4% | $24.85B+0.3% | $24.77B+0.0% | $24.76B |
| Diluted | $25.17B+0.2% | $25.13B+0.3% | $25.04B+0.4% | $24.94B+0.1% | $24.92B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Universal Corporation reported fiscal year 2026 revenues of $2,924.5M and diluted EPS of $1.30, down 66% from prior year, impacted by $41.1M goodwill impairment and $52.0M inventory write-downs
“Our disciplined marketplace management helped mitigate the impact of oversupply for certain tobacco styles, resulting in only slightly lower segment revenues”
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-03-02 | SLEDD ROBERT C | Director | Sale | 1,000 | $53.95 | $54K | 14.8K | View | |
| 2026-02-19 | 2026-02-23 | Freeman Lennart R. | Director | Sale | 3,746 | $53.45 | $200K | 16.0K | View |
Informational purposes only, not investment advice.